INDOCOBSEIndoco Remedies LtdMediumNeutral
Announced Tue, 13 Jan · 17:26 IST

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....

Promoter Stake BuyPromoter Stake Sell 1pctOwnership Changes View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kare Family Private Trust (KFPT), whose trustees are promoters Aditi Milind Panandikar and Madhura Suresh Kare, acquired 55,34,874 equity shares (6.00%) of Indoco Remedies directly from promoter Aruna Suresh Kare on 26th December 2025. KFPT also acquired 40% of promoter company Shanteri Investment Pvt Ltd (SIPL) and 20.16% of promoter group company SPA Holdings Pvt Ltd (SHPL), giving it indirect stakes of 17.19% and 19.88% in Indoco respectively. The transfer was an off-market inter-se transfer among immediate relatives at Nil consideration, done purely for family succession planning and to streamline family assets. Post-transaction, the promoter group's combined holding in KFPT totals 51.27% of Indoco (14.20% direct, 17.19% via SIPL, 19.88% via SHPL), while Aruna Suresh Kare's direct holding dropped from 6.00% to 0%. The disclosure was filed with SEBI on 13th January 2026 along with the required Rs.1,50,000 filing fee.

Likely market impact

This is a pure internal family restructuring with no change in total promoter control and no cash outflow, so it should have no meaningful impact on the stock price. The Kare family's combined promoter stake remains at 51.27%, and the shift consolidates their holdings under a single family trust for succession purposes.